Integrated Product Teams (IPTs) Sample Clauses

Integrated Product Teams (IPTs). The Sponsor(s) and the Consortium Members are encouraged to form IPTs to develop both White Papers for consideration as Research Initiatives in Project Proposals in response to the Sponsor(s)’s Project Proposal Announcement. In the event that IPTs are not formed at the White Paper or Proposal phase, after the selection and award of the Research Projects by the Sponsor(s), the Sponsor(s) and the Consortium Members agree, where applicable, to form IPTs to perform the Projects in response to sponsor requests.. The membership and meetings of the Integrated Product Teams and the IPT leaders will be determined by the Party having the responsibility to perform the specific Project. The IPTs will report progress of the Projects against established objectives to the Consortium. Where possible, the IPT leaders will participate as members of the appropriate Subcommittee.
View SourceView Similar (4)
Integrated Product Teams (IPTs). The Contractor shall establish a Government / Contractor Integrated Product Team (IPT) partnership to achieve synergy and efficiency for the mutual benefit of achieving the program goals. This IPT structure shall encompass, at a minimum, the management, contracting, test, and production processes.
View SourceView Similar (2)

Related to Integrated Product Teams (IPTs)

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Licensed Product The term “Licensed Product” shall mean any product (a) the manufacture, use, importation, sale or offer for sale of which would, in the absence of the license granted by this Agreement, infringe a Valid Claim of any of the Licensed Patent Rights, or (b) that is comprised of, utilizes or incorporates Licensed Biological Materials, or (c) that is discovered, developed or made using a Licensed Process.

  • Product Testing No later than [**] prior to a scheduled Delivery ARIAD US shall send to ARIAD SWISSCO the Delivery Documents for review. Following such review, unless within [**] of receipt of the Delivery Documents ARIAD SWISSCO gives written notice of rejection of the Product to be delivered, stating the reasons for such rejection, the Delivery shall proceed, and both Parties shall organize the same. Upon arrival at ARIAD SWISSCO nominated site it shall visually inspect the shipment of the Product to identify any damage to the external packaging. ARIAD SWISSCO may reject any shipment (or portion thereof) of the Product that is damaged by providing to ARIAD US reasonable evidence of damage within [**] after Delivery of such Product. If ARIAD SWISSCO does not so reject any shipment (or portion thereof) of the Product within [**] of Delivery of such Product, ARIAD SWISSCO shall be deemed to have accepted such shipment of the Product; provided, however, that in the case of the Product having any Latent Defect, ARIAD SWISSCO shall notify ARIAD US promptly once it becomes aware that a Product contains a Latent Defect and subsequently may reject such Product by giving written notice to ARIAD US of ARIAD SWISSCO’s rejection of such Product and shipping a representative sample of such Product or other evidence of Non-Conformance to ARIAD US within [**] after becoming aware of such Latent Defect, which notice shall include a description of the Latent Defect.